Study details
Enrolling now
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
Orhan Kemal Oz
NCT IDNCT04989959ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
35
Study length
about 6 years
Ages
18+
Locations
1 site in TX
What this study is about
Researchers are testing a new imaging test called [18F]PT2385 PET/CT to see if it can help doctors understand kidney cancer. This is an exploratory trial, meaning we are learning more about the test and how it works. It will involve taking biopsies of tumors in patients with kidney cancer to compare the results from the imaging test with those from a tissue sample.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take [18F]PT2385
- 2.Undergo Biopsy
- 3.Undergo Positron Emission Tomography/Computed Tomography
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
biopsy, imaging
Body systems
Oncology